CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
Increased serum levels of interleukin 1 receptor antagonist (IL-1ra) levels precede the onset of coronary heart disease: results from the MONICA/KORA Augsburg study
DOI 10.1055/s-0036-1580828
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Herder, T de las Heras Gala, C Huth, A Zierer, J Sudduth-Klinger, D Peretz, M Carstensen-Kirberg, S Wahl, C Meisinger, A Peters, M Roden, W Koenig, B Thorand
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Interleukin-1β (IL-1β) represents a key proinflammatory cytokine in the development of atherosclerosis and coronary heart disease (CHD). The activity of IL-1β is counter-regulated by interleukin-1 receptor antagonist (IL-1ra), an endogenous inhibitor. Data on the relevance of circulating IL-1ra levels for cardiovascular risk are scarce and inconsistent. Therefore, this study aimed (i) to examine the associatio…
Zitieren
Zitierempfehlung
C Herder, T de las Heras Gala, C Huth, A Zierer, J Sudduth-Klinger, D Peretz, M Carstensen-Kirberg, S Wahl, C Meisinger, A Peters, M Roden, W Koenig, B Thorand (2016) Increased serum levels of interleukin 1 receptor antagonist (IL-1ra) levels precede the onset of coronary heart disease: results from the MONICA/KORA Augsburg study. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0036-1580828
Mit CareLit weiterarbeiten